Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 18 pseudogene 7 (KRT18P7) is a pseudogene that shares sequence similarity with the functional keratin 18 gene (KRT18), a type I intermediate filament gene[5][6][7][8]. Pseudogenes are non-functional segments of DNA that resemble normal genes but typically lack the ability to encode a functional protein due to mutations or disruptions in their sequence[8]. KRT18P7 is one of several KRT18-related pseudogenes found in the human genome as processed pseudogenes—these arise from reverse-transcribed mRNA sequences integrated into the genome, particularly notable for keratins 8 and 18, whose pseudogenes are the most numerous within the keratin gene family[7][8]. KRT18P7 does not encode a functional protein, has no known biological function, is not associated with disease, does not interact with any drugs, and is not used as a biomarker. Its parental gene, KRT18, encodes an intermediate filament protein involved in epithelial cell structure and is a known biomarker for several epithelial-derived cancers; however, KRT18P7 itself is not clinically or pharmacologically relevant as a target[4][6][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 18 pseudogene 7 (KRT18P7).